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Background: Substantial opportunity exists to improve medication management in the period
following a hospital discharge. The objective of this study was to assess and improve medication
management during care transitions through pharmacist home visits and the use of an electronic
personal health record (ePHR) system.
Methods: Recently discharged patients aged 50 years or older and having a chronic medical
condition were offered the opportunity to meet with a pharmacist in the home setting to review
medication instructions and receive a demonstration of an ePHR system. Patients agreeable
to using the ePHR system were offered pharmacist support with setting up the ePHR system,
having emphasis on documenting and reviewing medication regimens. Medication-related
problems identified by the pharmacist during the visit were categorized according to ePHR use
and by other characteristics.
Results: Thirty recently discharged patients with chronic disease were visited by a pharmacist
over a 6-month period. The percentage of medication-related problems identified by the
pharmacist was greater among those patients who agreed to use the ePHR system, as compared
with patients whose visit did not include use of the ePHR (75% versus 40%, respectively;
P=0.06). Differing types of medication-related problems were identified, including therapy
duplications, lack of use of clinically important therapies, and patient nonadherence.
Conclusion: For some patients, the home setting can be a suitable venue for medication review
and education after discharge from hospital. Assisting patients with setting up the ePHR system
may enhance pharmacists’ ability to identify and resolve medication-related problems that may
lead to rehospitalization.
Keywords: medication reconciliation, care transition, electronic personal health record
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Patients who are recently discharged from hospital have an increased risk of
experiencing an adverse drug event, and more than half of such adverse drug events may
be preventable or ameliorable.1 In one study of the quality of medication instructions
following a hospitalization, Coleman et al reported that 14% of recently discharged
patients experienced a medication discrepancy, with an approximately equal proportion
of discrepancies resulting from patient-related or health system-associated factors.2
In another study of medication discrepancies at discharge, Wong et al reported that
over 40% of patients experienced at least one unintentional medication discrepancy.
In this study, incompletely written prescriptions and omissions of medications were
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identified as the most common types of errors.3 Yet even when
medication reconciliation is performed accurately during the
discharge process, patients may misunderstand medication
instructions, particularly when changes occur in complex
medication regimens. For example, in one review of medication reconciliation at discharge, Ziaeian et al detected either
a medication error or a lack of patient understanding about a
medication change in approximately 80% of patients.4
Payers, providers, and policy-makers have directed
increased attention and resources towards improving medication safety during care transitions. Current strategies include
implementing robust medication reconciliation processes,
and promoting other elements of good transitional care, such
as enhancing teamwork and communication, and utilizing
health information technologies. In 2012, the American
Pharmacists Association and the American Society of
Health-System Pharmacists jointly issued a white paper
entitled “Improving Care Transitions: Optimizing Medication
Reconciliation”.5 In this paper, these organizations describe
an expansive vision for medication reconciliation, one that is
“composed of multiple processes that together reduce medication errors, support safe medication use by patients, and
encourage community-based providers and those practicing
in hospitals and health systems to collaborate in organized
medication reconciliation programs to promote overall continuity of patient care”.
Health information technologies can improve medication
reconciliation functions.6,7 Patients can be empowered to
assume management of their medication regimen through
the use of an electronic personal health record system
(ePHR). Using the ePHR, patients or authorized caregivers
can maintain their medical information and medication list
using a secure electronic application. Patients, pharmacists,
and other care providers can utilize ePHR technology to
promote greater patient self-efficacy in self-management of
the medication regimen, and also to exchange and reconcile
information among various information repositories.8 While
these benefits are particularly apt during care transitions,
research assessing the utility of ePHR systems to improve
medication management is scant.9
Researchers from the University of Rhode Island College
of Pharmacy piloted an intervention to improve medication
management during care transitions. The project was one
of several initiatives included in the Tech4Impact Program
(Technologies for Improving Post-Acute Care Transitions),
sponsored by the Center for Technology and Aging,
a national leader in the use of patient-centered technologies
for older adults.
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Our intervention involved deploying pharmacists to visit
the homes of recently discharged patients to review medication instructions and to offer patients free use of an ePHR
system, with ongoing support in setting up and using the
ePHR. We hypothesized that the pharmacist’s ability to identify medication-related problems would be greater among
patients who used the ePHR system. To our knowledge, no
study to date has coupled in-home pharmacist education
with the use of an ePHR system to promote safe and effective medication management during care transitions. This
report presents our findings in delivering this intervention
during a 6-month period occurring between August 2011
and February 2012.

Materials and methods
This was a prospective nonrandomized pilot study in which
recently hospitalized patients were offered the opportunity to
meet with a pharmacist in their home within 14 days of their
discharge from hospital to review medication instructions
and to receive a demonstration of an ePHR system. Patients
were informed that the pharmacist home visit would include
a medication regimen review and help in setting up the
ePHR system, if desired. Usual care consisted of medication
reconciliation at discharge provided by hospital clinicians, but
without subsequent home visits provided by pharmacists.
The ePHR utilized in this project was the ER-Card® system, developed by ER-Card LLC of West Warwick, Rhode
Island. This product features online password-protected
sharing of health record information via the Internet, or by
USB drive provided by the consumer. The ER-Card system
provides staff support for assisting with completing and
updating the contents of the patient’s record. Medical conditions and medication information is self-reported by the
patient, with pharmacists verifying medication lists with the
patient’s pharmacy.
The study enrolled patients 50 years of age or older and
having any of the following chronic conditions: cardiovascular disease and related conditions (eg, atrial fibrillation),
respiratory illness (eg, chronic obstructive pulmonary
disease/asthma), and/or diabetes mellitus. As our focus was
on medication self-management among community-dwelling
patients, we did not recruit patients with dementia or patients
who were transitioning from the hospital to a long-term care
facility. The pharmacist home visit was offered to patients
who were participating in an associated care transitions
initiative conducted by the Rhode Island Quality Improvement Organization (Healthcentric Advisors) in cooperation
with Rhode Island’s Aging and Disability Resource Center.
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Patients were also recruited via referral from Rhode Island
Medicaid nurse case managers. A third pathway for patient
recruitment was on-site solicitation of patients at Kent
Hospital in Warwick, Rhode Island, which served as the
predominant patient recruitment source.
Patients agreeable to the pharmacist home visit completed
an informed consent process explaining the activities that
the pharmacist would be providing during the home visit.
Patients were informed that that they were not required to
utilize the ePHR system to receive the pharmacist home visit,
and that if they decided to utilize the ePHR system, their
information could be shared with other health care providers
only if they provided permission. Those patients deciding to
utilize the ePHR system completed an authorization form
routinely required by the ePHR vendor for compliance with
the Health Insurance Portability and Accountability Act. The
ePHR was offered to patients at no cost, and patients were
allowed to discontinue their use of the ePHR at any time.
The study was approved by the Institutional Review Board
on Human Subjects at the University of Rhode Island and
Kent Hospital.
For patients consenting to participate in the study, a home
visit was scheduled by the study pharmacist for a suggested
period of 2 hours. When a medication-related problem was
identified during the medication review, the pharmacist
discussed the concern with the patient, and encouraged
the patient to contact the prescriber or pharmacy when
appropriate. The pharmacist demonstrated the ePHR program
using a laptop computer, and if the patient was agreeable to
trying the ePHR system, the pharmacist supported the patient
in entering their medical information and medication list
into the ePHR system. During the home visit the pharmacist
completed a data collection form that captured information
describing the medication-related problems identified and
other data relevant to the study.
We categorized study participants according to the referral source and by the primary diagnosis associated with the
recent hospitalization. Age was categorized as 50–64 years
or 65 years or older. We categorized the types of medicationrelated problems identified during the home visit as involving
therapy duplication, interactions, medication cost, or incorrect use or underuse of a medication (eg, poor adherence).
We compared the frequency of medication-related problems
identified between users and nonusers of the ePHR system,
overall and according to patient age and sex. We also documented medication discrepancies using the tool developed
by Dr Eric A Coleman’s Care Transitions Program®,10 which
categorizes events as patient-related or health-system related.
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Our results are presented here as descriptive statistics, with
the chi-square test used to determine the statistical significance of differences in observed rates of medication-related
problems between users and nonusers of the ePHR. Fisher’s
exact test was used where any cell size was less than five
observations.
We attempted to contact patients no earlier than 30 days
following the home visit to enquire about their satisfaction
with the pharmacist visit, to determine if patients continued
to utilize the ePHR system, and to ascertain if patients had
been rehospitalized in the period following the home visit.

Results
Approximately 300 patients were identified as eligible for
our program and were approached by study recruiters. While
59 of these eligible patients initially agreed to participate
in the study, we were unable to schedule a home visit with
29 patients, because some did not return our subsequent telephone calls to schedule the home visit, while other patients
changed their mind about participating, transitioned to a
long-term care setting or died. The study pharmacists completed home visits for a total of 30 patients, with 20 of these
patients agreeing to utilize the ePHR system. Among the
30 patients visited, 16 (53%) were male and 23 (77%) were
65 years of age or older. The majority of patients had been
hospitalized due to a cardiovascular-related illness (n=24),
while six patients were hospitalized for an exacerbation of
their respiratory illness or diabetes (see Table 1).
At each patient home visit, the pharmacist performed a
medication regimen review and documented medicationrelated problems that were identified. Table 2 presents
the range of problems discovered, which are categorized
Table 1 Characteristics of patients with chronic disease com
pleting a pharmacist home visit following a hospitalization (n=30)
Recruitment source
 In-hospital recruitment
Medicare QIO referral
Medicaid RN referral
Patient age (years)
50–64
65+
Sex
Female
Male
Primary diagnosis
 Cardiovascular
 Respiratory
Diabetes

n

%

20
7
3

66.7
23.3
10.0

7
23

23.3
76.7

14
16

46.7
53.3

24
3
3

80.0
10.0
10.0

Abbreviations: QIO, quality improvement organization; RN, registered nurse.
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Table 2 Examples of medication-related problems identified
during pharmacist home visits following hospital discharge
Cost-related

Medication underuse

• Patient discontinued
antiplatelet medication
due to cost
• Patient discontinued
cholesterol medication
due to cost
• Patient discontinued
anticoagulant medication
due to cost

• Diabetes and post-myocardial
infarction: no aspirin, ACEI/ARB,
or statin prescribed
(not contraindicated)

Therapy duplication

• Patient did not continue aspirin
therapy as instructed (intentional
nonadherence)
• Diabetes, no ACEI/ARB
prescribed (not contraindicated)
Incorrect medication use

• Patient taking multiple
acetaminophencontaining products
• Patient taking both
omeprazole and
esomeprazole
• Duplication of albuterol
(use of two different
brand name inhalers)
Drug interactions

• Patient taking albuterol inhaler
three puffs once daily instead of
one puff three times a day as
ordered
• Patient using sublingual
nitroglycerin incorrectly

• Patient taking thyroid
medication at same time
as calcium supplement

• Patient uncertain if supposed
to continue or stop antiplatelet
medication

• Patient unaware of
drug-food (alcohol)
interactions
• Use of both enoxaparin
and warfarin with no plan
to stop either drug

• Different dose of medication
taken at home versus what is
documented on discharge
instructions

Unclear instructions

Abbreviations: ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensinreceptor blocker.

as cost-related, involving therapeutic duplication, drug
interaction, underuse (lack of use) of a clinically important
therapy, or having incorrect or unclear instructions for
medication use. Several patients discontinued a clinically
important medication due to cost, while other patients did
not appear to be utilizing indicated therapies (eg, lack of
aspirin use following a myocardial infarction, with no
apparent contraindication to aspirin therapy). Instances
of therapeutic duplication included concomitant use of
two proton pump inhibitors, use of two different albuterol
inhaler products, and use of multiple products containing
acetaminophen.
The percentage of medication-related problems detected
by the pharmacist was higher among those patients agreeing
to use the ePHR system (15/20, 75%), as compared with
patients who did not use the ePHR (4/10, 40%). Medicationrelated problems were also identified more frequently among
patients who were younger than 65 years of age, as compared
with older patients (71% versus 61%, respectively), and
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were identified more frequently among males as compared
with females (69% versus 57%, respectively). Medicationrelated problems were identified among approximately 60%
of patients who were recently hospitalized for a cardiovascular-related condition, and among 67% of patients who
were recently hospitalized for a respiratory illness. Despite
large proportional differences across several of these crosstabulations, statistically significant differences were not
observed, reflecting the small sample size in this pilot study
(Table 3).
Table 4 presents the frequencies and types of medication
discrepancies identified during the home visit using the Care
Transitions Program® Medication Discrepancies Tool for
Multiple Events.10 Discrepancies were detected among 16 of
the 30 patients we visited (53%): six of the discrepancies were
categorized as relating to patient-associated factors, while ten of
the discrepancies were considered to have resulted from systemrelated factors. The most frequently observed discrepancy was
“conflicting information from different informational sources”, as
documented in five of the 30 home visits that were completed.
We succeeded in following up with 19 of the 30 patients
whom we visited. Of these 19 patients, three had been
Table 3 Frequency of medication-related problems identified
during home visit following discharge: results stratified by ePHR
use, recruitment source, and other patient characteristics
Characteristic (n)

ePHR use
Yes (20)
 No (10)
Recruitment source
 In hospital (20)
 QIO/ADRC
referral (7)
 Medicaid referral (3)
Patient age
50–64 years (7)
65+ years (23)
Sex
Female (14)
Male (16)
Primary diagnosis
 Cardiovascular (24)
 Respiratory (3)
Diabetes (3)

Medication
problem(s)
was identified
at visit

No
Medication
problem(s)
identified
at visit

n

%

n

%

15
4

75.0
40.0

5
6

25.0
60.0

12
5

60.0
71.4

8
2

40.0
28.6

2

66.7

1

33.3

0.851

5
14

71.4
60.9

2
9

28.6
39.1

0.901

8
11

57.1
68.8

6
5

42.9
31.2

0.707

14
2
3

58.3
66.7
100

10
1
0

41.7
33.3
0

0.542

P-value*

0.061

Note: *Chi-square/Fisher’s exact test.
Abbreviations: QIO, quality improvement organization; ADRC, Aging and
Disability Resource Center; ePHR, electronic personal health record.
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Table 4 Medication discrepancies identified during pharmacist
home visits following a hospital discharge (n=30)*
Patient-associated factors

System-associated factors

• Adverse drug reaction or
side effects (n=0)
• Intolerance (n=0)
• Did not fill/need
prescription (n=0)
• Money/financial
barriers (n=3)
• Intentional
nonadherence (n=2)
• Nonintentional
nonadherence (n=1)
• Performance deficit (n=0)
Total 6/30 (20%)

• Prescription with known allergy/
intolerance (n=0)
• Conflicting information from different
informational sources (n=5)
• Confusion between brand versus
generic name (n=0)
• Discharge instructions incomplete,
inaccurate, or illegible (n=1)
• Duplication (n=3)
• Incorrect dosage (n=0)
• Incorrect quantity (n=0)
• Incorrect label (n=0)
• Cognitive impairment not
recognized (n=0)
• Need for assistance not
recognized (n=1)
Total 10/30 (33.3%)

Notes: *Sixteen discrepancies in total identified among 30 patients visited (53.3%).
Identified using the Medication Discrepancy Tool for multiple events, Care
Transitions Program® (http://www.caretransitions.org/).

rehospitalized within 30 days (3/19, 16%). Patients who
were surveyed at follow-up expressed a high level of satisfaction with the pharmacist home visit, with all patients
responding affirmatively to our follow-up survey question:
“Do you think that the pharmacist home visit was helpful in
reviewing your medications and addressing your questions?”
Seven patients reported that they had used the ePHR to share
information with care providers during their post-discharge
medical visits.

Discussion
In this pilot program, pharmacists conducting home visits
frequently identified medication-related problems among
recently discharged patients. At least three of the 30 patients
had discontinued an important medication therapy due to high
cost. In these instances, the pharmacist instructed the patient
to contact her/his health care provider to discuss treatment
options, which might include switching to an affordable
alternative therapy (eg, changing to a generic cholesterollowering medication). Additionally, several patients reported
errors related to their medication regimen that occurred
during their transitioning into or out of hospital, with 16
such discrepancy events documented using the Medication
Discrepancy Tool®.
Among the 30 patients who were visited by the pharmacist, 20 agreed to use the ePHR technology, and seven
patients reported that they had used the ePHR to share
information with their care providers during follow-up visits
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or rehospitalizations. While these results indicate that the
ePHR system can be effectively used by patients during care
transitions, our sample size was too small to draw any firm
conclusions regarding the characteristics of patents who are
more likely to effectively utilize an ePHR to manage their
medication regimen.
This intervention was challenging to operationalize.
Foremost, patient recruitment was difficult, because many
of the patients whom we encountered were not agreeable
to meeting with the pharmacist in their home. Patient perceptions regarding the role of the pharmacist in the health
system may have posed a barrier to our work, as pharmacists
do not commonly enter the patient’s home to provide medication counseling services. The lack of awareness among
patients of the potential benefits of an ePHR system also
posed a barrier to recruitment. We provided an explanation of the ePHR system and its potential benefits during
recruitment, and as an element of the informed consent
process. However, it was challenging to effectively explain
the potential utility of the ePHR during our brief recruitment
encounters, especially considering that our population of
focus included hospitalized or recently hospitalized patients
who were often severely ill. Additionally, approximately
half of the patients who consented to participate in the
study subsequently changed their mind about completing
the home visit, or did not return telephone calls when the
scheduler contacted them.
Our study had several limitations that should be considered in interpreting our findings. Most importantly, it should
be recognized that this was a pilot study involving a small
number of patients. Larger scale application of the model is
warranted before any strong conclusions can be made about
the benefits of ePHR systems to aid medication management
during care transitions. The small sample size also limited
our ability to determine a difference in effectiveness of the
intervention according to the characteristics of the patients
studied. Additionally, the nonrandomized design may have
resulted in selection bias, whereby participating patients may
have generally been more accepting of the role of pharmacists
and of information technology. Another limitation of our
study pertains to the role of the pharmacist in our model,
which did not include direct intervention with the patient’s
pharmacy or prescribers to pursue each medication-related
problem identified to its resolution. We believe that establishing more formalized communications with health care team
members would be an important step towards ensuring that
the visiting pharmacist’s observations and recommendations
are best incorporated into clinical decision-making. Finally,
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we were unable to follow up with 11 of the 30 patients to
determine their satisfaction with the intervention, or if they
continued to use the ePHR system.

Conclusion
Our findings from this pilot study suggest that pharmacist
home visits following a hospitalization can aid in identifying medication-related problems. The frequency and clinical
significance of the problems identified suggests a need for
increased involvement of pharmacists during care transitions.
The ability to identify such problems may be enhanced when
pharmacists work together with patients to review and enter
the discharge medication list into an ePHR system.
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